Overall, phospholipid and sphingolipid metabolism showed a decreasing trend after HIF-PHI treatment.
← all excerpts
Plasma phospholipids profiling changes were associated with the therapeutic response to Roxadustat in peritoneal dialysis patients.
1
—
—